Beth Israel Deaconess Medical Center (Boston). The BIDMC Cancer Center has more than 160 faculty; receives more than $70 million in annual research funds; and offers 20 specialty programs. The hospital is a Blue Distinction Center for Complex & Rare Cancers for eight cancer types and received a “high performing” national ranking for cancer care by U.S. News & World Report for 2016-17. The cancer center recently named a new clinical director, Manuel Hidalgo, MD, PhD, a pancreatic cancer specialist who now oversees BIDMC clinical cancer programs.
| ← Previous Next →
|
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
